Progress in embolic agents carry anti-angiogenesis drugs

来源 :2016第十二届亚太介入放射学大会 | 被引量 : 0次 | 上传用户:aorong
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Transcatheter embolization is an important technology of tumor interventional therapy,by controlling embolic agents injected into the tumor blood vessels,blocking blood vessels and blood supply to play a therapeutic role in cancer.But the tumor will be ischemia and hypoxia after embolization,often induce angiogenesis indirectly,promote tumor recurrence and metastasis.
其他文献
会议
会议
会议
会议
会议
会议
Objective:In the basis of safety evaluation of applying hydrochloric acid combined with radiofrequency ablation(HRFA)to rabbits livers,we evaluate the safety of HRFA in treating medium and large hepat
Purpose:To assess the efficacy,feasibility and safety of CT-guided percutaneous cryoablation of local recurrence Desmoid-type Fibromatosis.
Objective:To explore the security,short-term curative effect and mechanism of action of PVA and KMG Containing Nordy in rabbit VX2 liver transplantation tumor.
Purpose:To assess the feasibility and safety of percutaneous intraductal radiofrequency ablation combined with bilateral stents implantation in unresectable Bismuth types Ⅲ and Ⅳ hilar cholangiocarcin